Roussot N, Kaderbhai C, Ghiringhelli F
Cancers (Basel). 2025; 17(5).
PMID: 40075753
PMC: 11898530.
DOI: 10.3390/cancers17050906.
Raposo C, Yan P, Chen A, Majidi S, Hiam-Galvez K, Satpathy A
bioRxiv. 2025; .
PMID: 39990338
PMC: 11844384.
DOI: 10.1101/2025.02.10.637523.
Gago da Graca C, Sheikh A, Newman D, Wen L, Li S, Shen J
Sci Immunol. 2025; 10(103):eadn1945.
PMID: 39888981
PMC: 7617396.
DOI: 10.1126/sciimmunol.adn1945.
Zhao S, Tian D, Huang F, Wang L, Cheng J, He Z
Cancer Cell Int. 2025; 25(1):29.
PMID: 39885569
PMC: 11783933.
DOI: 10.1186/s12935-025-03659-4.
Zhu G, Tang Z, Chu T, Wang B, Chen S, Tao C
Signal Transduct Target Ther. 2025; 10(1):25.
PMID: 39837814
PMC: 11751439.
DOI: 10.1038/s41392-024-02118-2.
Current landscape of immunotherapy in esophageal cancer: a literature review.
Moughnyeh M, Green M, Katuwal B, Hammoud Z
J Thorac Dis. 2025; 16(12):8807-8814.
PMID: 39831204
PMC: 11740023.
DOI: 10.21037/jtd-24-1145.
An early precursor CD8 T cell that adapts to acute or chronic viral infection.
McManus D, Valanparambil R, Medina C, Scharer C, McGuire D, Sobierajska E
Nature. 2025; .
PMID: 39778710
DOI: 10.1038/s41586-024-08562-y.
RSV Vaccine with Nanoparticle-Based Poly-Sorbitol Transporter (PST) Adjuvant Improves Respiratory Protection Against RSV Through Inducing Both Systemic and Mucosal Humoral Immunity.
Jung S, Kim S, Park Y, Seo E, Kim C, Kim T
Vaccines (Basel). 2025; 12(12.
PMID: 39772016
PMC: 11680183.
DOI: 10.3390/vaccines12121354.
Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy.
Godiyal Y, Maheshwari D, Taniguchi H, Zinzuwadia S, Morera-Diaz Y, Tewari D
Mil Med Res. 2024; 11(1):82.
PMID: 39690423
PMC: 11654217.
DOI: 10.1186/s40779-024-00586-9.
Miltefosine reinvigorates exhausted T cells by targeting their bioenergetic state.
Zhang X, Zhang C, Lu S, Dong J, Tang N, Wang Y
Cell Rep Med. 2024; 5(12):101869.
PMID: 39657666
PMC: 11722131.
DOI: 10.1016/j.xcrm.2024.101869.
Integrative mapping of human CD8 T cells in inflammation and cancer.
Xue Z, Wu L, Tian R, Gao B, Zhao Y, He B
Nat Methods. 2024; 22(2):435-445.
PMID: 39614111
DOI: 10.1038/s41592-024-02530-0.
Relationship Between Loss of Y Chromosome and Urologic Cancers: New Future Perspectives.
Russo P, Bizzarri F, Filomena G, Marino F, Iacovelli R, Ciccarese C
Cancers (Basel). 2024; 16(22).
PMID: 39594721
PMC: 11593089.
DOI: 10.3390/cancers16223766.
Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities.
Li J, Zhou W, Wang H, Huang M, Deng H
MedComm (2020). 2024; 5(12):e70019.
PMID: 39584047
PMC: 11586091.
DOI: 10.1002/mco2.70019.
Various Strategies of Tendon Stem/Progenitor Cell Reprogramming for Tendon Regeneration.
Ahn S
Int J Mol Sci. 2024; 25(21).
PMID: 39519296
PMC: 11547070.
DOI: 10.3390/ijms252111745.
The ovarian cancer-associated microbiome contributes to the tumor's inflammatory microenvironment.
Zhang M, Mo J, Huang W, Bao Y, Luo X, Yuan L
Front Cell Infect Microbiol. 2024; 14:1440742.
PMID: 39497925
PMC: 11532186.
DOI: 10.3389/fcimb.2024.1440742.
NF-κB signaling pathway in tumor microenvironment.
Cao Y, Yi Y, Han C, Shi B
Front Immunol. 2024; 15:1476030.
PMID: 39493763
PMC: 11530992.
DOI: 10.3389/fimmu.2024.1476030.
HSPD1 Supports Osteosarcoma Progression through Stabilizing ATP5A1 and thus Activation of AKT/mTOR Signaling.
Zhang Y, Pan R, Li K, Cheang L, Zhao J, Zhong Z
Int J Biol Sci. 2024; 20(13):5162-5190.
PMID: 39430254
PMC: 11489178.
DOI: 10.7150/ijbs.100015.
Establish a novel immune-related gene prognostic risk index (IRGPRI) associated with CD8+ cytotoxic T lymphocytes in non-small-cell lung cancer (NSCLC).
Cui S, Yang Y, Lou S, Huang R, Wang J, Chen Z
Heliyon. 2024; 10(19):e38324.
PMID: 39397989
PMC: 11466668.
DOI: 10.1016/j.heliyon.2024.e38324.
CAR-redirected natural killer T cells demonstrate superior antitumor activity to CAR-T cells through multimodal CD1d-dependent mechanisms.
Zhou X, Wang Y, Dou Z, Delfanti G, Tsahouridis O, Pellegry C
Nat Cancer. 2024; 5(11):1607-1621.
PMID: 39354225
DOI: 10.1038/s43018-024-00830-0.
Tim-3 Is Required for Regulatory T Cell-Mediated Promotion of T Cell Exhaustion and Viral Persistence during Chronic Lymphocytic Choriomeningitis Virus Infection.
Nieves-Rosado H, Banerjee H, Gocher-Demske A, Manandhar P, Mehta I, Ezenwa O
J Immunol. 2024; 213(10):1488-1498.
PMID: 39345172
PMC: 11671103.
DOI: 10.4049/jimmunol.2400119.